BIOXYNE LIMITED — Capital/Financing Update 2017

Apr 12, 2017

==> picture [333 x 175] intentionally omitted <==

MARKET RELEASE

13 April 2017

BIOXYNE LIMITED

TRADING HALT

The securities of Bioxyne Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Wednesday, 19 April 2017 or when the announcement is released to the market.

Security Code: BXN

Andrew Kabega SENIOR ADVISER, LISTINGS COMPLIANCE (SYDNEY)

==> picture [596 x 109] intentionally omitted <==

----- Start of picture text ----- Suite 506, Level 5, 50 Clarence StSydney NSW 2000P: +61 2 9078 8180W: www.bioxyne.com----- End of picture text -----

13 April 2017

The Manager Issuers Department Australian Securities Exchange

Attention: Johanna O’Shea

Request for a Trading Halt

Bioxyne Limited (ASX:BXN) requests a trading halt to the trading of the company’s securities until the earlier of an announcement in relation to an acquisition and capital raising or Wednesday 19 April 2017.

In accordance with listing rule 17.1 the company advises that:

1. The trading halt is necessary as the Company expects to make an announcement to the market in relation to an acquisition and capital raising outlined above.

2. The company wishes the trading halt to last until as such time it makes an announcement to the market concerning details of the acquisition and capital raising or Wednesday 19 April 2017, whichever is the earlier.

3. The company is not aware of any reason why the trading halt should not be granted.

Yours faithfully

==> picture [124 x 92] intentionally omitted <==

Guy Robertson Company Secretary

==> picture [455 x 49] intentionally omitted <==